Fighting childhood cancer, one cup at a time.
| » View all news titles |
» View titles this week |
» View titles this month |
UT Southwestern Medical Center
03/29/2018
A first-of-its-kind drug targeting a fused gene found in many types of cancer was effective in 93 percent of pediatric patients tested, researchers at UT Southwestern’s Simmons Cancer Center announced.
Penelope was a little over 2 years old when she was diagnosed with rhabdomyosarcoma. Chemotherapy initially expanded her tumor, but doctors were then able to remove it safely. Penelope is nearing the end of treatment and continues to amaze her parents. Read more »
Our Scientific Advisory Board chooses projects that are likely to make critical contributions to current pediatric cancer research and play a part in bringing the latest and most promising lifesaving treatments for these children.
Read more »